Felodipine

Quick links to important sections

Felodipine

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Felodipine

What is Felodipine?

Felodipine is an oral medication belonging to a class of drugs known as calcium channel blockers, specifically the dihydropyridine subclass. It is primarily used to manage high blood pressure (hypertension). By influencing the movement of calcium into the muscle cells of the arterial walls, felodipine helps to relax and widen the blood vessels, which facilitates easier blood flow and reduces the workload on the heart.

Mechanism of Action

As a calcium antagonist, felodipine inhibits the influx of extracellular calcium ions through specific channels in the membranes of vascular smooth muscle and cardiac muscle cells. However, felodipine is highly selective for the smooth muscle in the walls of peripheral blood vessels compared to the muscle of the heart itself. This selectivity allows the medication to lower peripheral vascular resistance and decrease blood pressure without significantly affecting the heart's contraction strength or electrical conduction.

Key Characteristics

  • Vascular Selectivity: Felodipine focuses its activity on the systemic arteries, leading to vasodilation.
  • Pharmacological Class: It is categorized as a long-acting dihydropyridine calcium channel blocker.
  • Therapeutic Intent: The primary goal of treatment is the long-term management of arterial hypertension to help prevent complications associated with elevated blood pressure.

Felodipine is typically formulated as extended-release tablets to ensure a steady release of the medication into the bloodstream over a 24-hour period, allowing for consistent blood pressure control.

What side effects are possible with Felodipine?

Felodipine: Possible Side Effects and Safety Information

Adverse reactions documented in official regulatory sources are systematically classified by frequency and System-Organ Class. Many common dose-dependent reactions are officially noted to be transient and often diminish with time, frequently appearing at the start of treatment or after a dose increase.


Frequency-Classified Adverse Reactions

The following are examples of adverse events classified by their observed incidence in regulatory documents:

Classification Examples of Documented Reactions
Very Common (ge 1/10) Peripheral oedema, Headache
Common (ge 1/100 to <1/10) Flushing
Uncommon (ge 1/1,000 to <1/100) Dizziness, Fatigue, Nausea, Hypotension, Tachycardia
Very Rare (<1/10,000) Gingival hyperplasia, Angio-oedema, Increased liver enzymes

Adverse reactions are also grouped by affected systems, including Vascular disorders, Nervous system disorders, Gastrointestinal disorders, and Skin and subcutaneous tissue disorders.


Serious and Population-Specific Safety Notes

Serious adverse reactions officially listed include rare, severe hypersensitivity reactions such as angio-oedema. The documentation also notes the possibility of aggravation of angina or paradoxical chest pain after treatment initiation in certain susceptible individuals.

Official prescribing information defines specific contraindications where the medicine should not be used, including decompensated heart failure, acute myocardial infarction, unstable angina pectoris, and pregnancy. Furthermore, hepatic impairment may lead to elevated plasma concentrations, and the medicine is not recommended during lactation.

Overdose and Emergency Response

Felodipine Overdose and when to seek help

The officially documented manifestations of Felodipine overdosage are consistent with its pharmacological class, focusing on severe effects on the cardiovascular system. Overdose is characterized by excessive peripheral vasodilatation, which leads directly to marked hypotension (severely low blood pressure) and may also result in bradycardia (slow heart rate). This presentation requires immediate attention due to the severe outcomes associated with profound hypotension, which is the critical regulatory concern.


When to Seek Immediate Medical Help

Regulatory authorities mandate that immediate medical attention must be sought if overdosage is suspected. Contact the Poison Control Center for specialized guidance on treatment. Emergency services must be called immediately if the individual collapses, has a seizure, has trouble breathing, or is unresponsive.


Official Overdose Management

Management of Felodipine overdose is symptomatic and supportive, as no specific antidote is documented. Treatment focuses on managing the cardiovascular effects. If severe hypotension occurs, the label instructs that the patient should be placed supine with the legs elevated. For documented bradycardia, the specific procedural measure of administering Atropine intravenously is described. Initial measures may include activated charcoal or gastric lavage, if medically appropriate and justified.

Therapeutic Uses of Felodipine

What Felodipine Treats: Main Uses and Benefits

Felodipine is an approved medication utilized for the management of hypertension (high blood pressure). It is a therapeutic option for individuals with essential hypertension, which refers to high blood pressure without a known secondary cause. The use of this drug is intended to lower blood pressure levels.

Controlling high blood pressure is a fundamental component of comprehensive cardiovascular risk management. By assisting in the reduction of blood pressure, Felodipine may assist in reducing the risk of serious non-fatal and fatal cardiovascular events, including stroke and myocardial infarction (heart attack). These potential benefits align with observed outcomes in controlled clinical trials of antihypertensive treatments.

It may be used alone or in combination with other antihypertensive agents to achieve adequate blood pressure control.


Quick Facts

  • Primary Use: Treatment for the management of essential hypertension.
  • Benefit: May assist in lowering blood pressure.
  • Goal: Aims to support the reduction of cardiovascular risk.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Felodipine is primarily prescribed to adults for the treatment of high blood pressure (hypertension) and angina. Most adults over the age of 18 may be able to use it, but several pre-existing conditions and life stages can prevent its use or require extreme caution and dose adjustment.

Contraindications (Should Not Use)

Felodipine is generally not suitable for individuals with:

  • Known allergy or hypersensitivity to felodipine or any other dihydropyridine calcium channel blocker.
  • Uncompensated heart failure.
  • Acute myocardial infarction (recent heart attack).
  • Unstable angina pectoris (new or worsening chest pain).
  • Pregnancy (use is typically avoided or substituted due to potential risks to the fetus).

Precautions (Use with Caution)

Your healthcare provider may prescribe felodipine with caution, often starting at a lower dose, if you have:

  • Significant liver impairment, as this can affect the drug's metabolism.
  • Severe aortic stenosis or other dynamic cardiac outflow obstructions.
  • Breastfeeding, as the drug passes into breast milk, and the effects on the infant are not fully established.

It is essential to inform your doctor about all your medical conditions and all other medications, supplements, and herbal products you use before starting felodipine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Felodipine's interaction profile is primarily governed by its metabolism through the Cytochrome P450 3A4 (CYP3A4) enzyme system. Coadministration with drugs that either increase or decrease the activity of this enzyme can significantly alter the concentration of felodipine in the body, which may compromise its intended effect or increase the risk of adverse reactions.

Documented Interaction Categories

Interaction Type Examples (Specific Agents Listed) Regulatory Recommendation
CYP3A4 Inhibitors Itraconazole, Erythromycin, Cimetidine, Grapefruit juice Avoid concurrent use (risk of increased felodipine exposure)
CYP3A4 Inducers Rifampicin, Phenytoin, Carbamazepine, St. John's wort Avoid concurrent use (risk of decreased felodipine exposure)

Other Significant Interactions

Felodipine may increase the plasma concentration of Tacrolimus (an immunosuppressant), which requires careful monitoring of Tacrolimus blood levels and appropriate dose adjustment when these medications are used together. Due to the high risk of exposure changes, official regulatory labeling advises against the concomitant use of felodipine with strong inhibitors or strong inducers of the CYP3A4 enzyme, including certain antifungals, antibiotics, and anti-epilepsy medicines. The consumption of grapefruit juice must also be avoided as it acts as a strong CYP3A4 inhibitor.

Mechanism of Action

Felodipine is a selective dihydropyridine calcium channel blocker that targets and inhibits the L-type Voltage-Gated Calcium Channels on arterial smooth muscle cells. This action prevents the influx of extracellular calcium ions (Ca^2+), which are essential for initiating muscle contraction. By stabilizing these channels in their inactive state, Felodipine directly interferes with the excitation-contraction coupling pathway in the arterial walls.

The cellular effect of calcium blockade leads to the relaxation and consequent widening (vasodilation) of the resistance arteries, or arterioles. This physiological change decreases the total opposition to blood flow known as Systemic Vascular Resistance (SVR), reducing the cardiac afterload and resulting in a state of lowered vascular tension.

While this action decreases resistance, the physiological shift triggers the body's baroreceptor reflex as a constraint mechanism. This reflex is the autonomic counter-regulatory response to rapid vasodilation and results in a compensatory, reflex increase in heart rate (tachycardia). Furthermore, the drug exhibits a secondary effect of Mineralocorticoid Receptor antagonism, which modulates fluid balance pathways.

Dosage and Administration Information

How to Use Felodipine

Felodipine is prescribed as an extended-release tablet for oral administration. Adherence to the official labeled instructions is critical to ensure the medication works as intended.

Administration and Dosage

Guideline Instruction
Route & Form Swallow the extended-release tablet whole; do not crush, divide, chew, or break it, as this would compromise the prolonged-release action.
Frequency Take the tablet once daily in the morning, ideally at the same time each day.
Dosing The typical starting dose is 2.5 mg to 5 mg once daily. Doses should not exceed 10 mg once daily, as higher amounts increase the risk of adverse effects.

Special Procedural Rules

The medication can be taken without food or with a light meal low in fat and carbohydrates. It must not be taken with a heavy, high-fat, or high-carbohydrate meal, as this may impact absorption.

Furthermore, grapefruit and grapefruit juice must be entirely avoided while taking felodipine, as this combination can significantly increase the concentration of the drug in the body.

Population-Specific Dosing

Lower starting doses of 2.5 mg once daily are typically recommended for older patients and those with impaired liver function.

Handling Missed Doses

If a dose is missed, skip that dose and take the next one at the regularly scheduled time. Do not take a double dose to compensate for the missed one.

Recent Clinical Evidence

Evidence for Use in Managing High Blood Pressure (Hypertension)

Research for Felodipine has primarily focused on conditions characterized by high blood pressure (essential hypertension) as defined by its regulatory authorization. Studies were conducted using Randomized Controlled Trials (RCTs), a design that compares patient groups receiving the study medication to groups receiving a placebo. Short-term RCTs, often lasting between four and eight weeks, examined how Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) measurements evolved during the study period.


Outcomes Measured in Felodipine Trials

Beyond blood pressure changes, trials monitored intermediate endpoints related to physiological strain or stress. Research examined measurements of cardiac structure, such as the size and thickness of the heart muscle (Left Ventricular Hypertrophy or LVH). Large-scale studies were also conducted for their role in long-term clinical events, exploring whether administration of the medication was associated with differences in the occurrence of fatal and non-fatal stroke and myocardial infarction (heart attack).


Evidence in Special Patient Groups and Limitations

Research explored specific cohorts, including older adults with Isolated Systolic Hypertension (ISH), and reported patterns of blood pressure measurements similar to those observed in the broader adult study populations. However, data for certain groups, such as children, pregnant individuals, or those with certain pre-existing organ damage, are limited or lacking. Follow-up durations were limited in many initial trials, and some large long-term trials primarily enrolled patients from a specific ethnic population, meaning the applicability of observed patterns may be restricted. Research is ongoing, but the existing evidence highlights what is known — and what is still uncertain — about the research findings across the full spectrum of patients included in the studies.

Key Studies & References

  1. Felodipine: Drug information - NIH MedlinePlus
  2. Felodipine Pharmacology (NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Felodipine (FAQ)


Q: Does Felodipine work by relaxing the arteries?

A: Yes, Felodipine is classified as a calcium antagonist that works primarily by relaxing and widening the blood vessels, particularly the arteries. This action helps to reduce the resistance to blood flow, which in turn helps to lower blood pressure. This mechanism is the foundation of the drug's therapeutic effect.

Q: Is it normal to feel a bit dizzy when first taking Felodipine?

A: Dizziness is noted in regulatory documents as an uncommon side effect, meaning it is not experienced by most people. Official information suggests that reactions like dizziness are usually transient and may lessen over time, especially as the body adjusts at the start of treatment. If dizziness is persistent or severe, it should be discussed with a healthcare professional.

Q: Is Felodipine a type of beta-blocker?

A: No, Felodipine is not a beta-blocker. It belongs to a different class of cardiovascular medicines known as dihydropyridine calcium channel blockers, or calcium antagonists. This means it works by blocking the entry of calcium into the muscle cells of your blood vessels, which is a mechanism distinct from that of beta-blockers.

Q: How long does Felodipine stay in your system?

A: According to the official pharmacokinetic information, Felodipine is rapidly cleared from the body. Its elimination half-life—the time it takes for half of the drug to be cleared—typically ranges from about 18 to 29 hours in adults. This controlled clearance profile is why the medication is formulated as an extended-release, once-daily tablet.

Q: Is it okay to have alcohol while on Felodipine, and if so, how much?

A: Regulatory documents advise caution regarding alcohol consumption while taking Felodipine. Alcohol and the medication can have combined effects that further lower blood pressure. Due to the potential for increased side effects such as dizziness or fainting, consumption of alcohol should be approached with caution.

Q: Can women who are planning pregnancy use Felodipine?

A: Felodipine is generally contraindicated (should not be used) during pregnancy due to potential risks identified in non-clinical studies. Since the drug is generally not recommended during pregnancy, individuals planning pregnancy should discuss their treatment plan with a healthcare provider to explore appropriate alternatives.

Q: Can Felodipine make you tired or lethargic?

A: Yes, fatigue is listed in the official drug information as an uncommon side effect, meaning it is not frequent. If any fatigue or tiredness is a concern, it is best to consult a healthcare provider.

Q: Is there any research on long-term safety of Felodipine?

A: Official regulatory approval for the chronic management of hypertension implies that long-term safety and effectiveness are established. Clinical summaries confirm this safety foundation, though they also note that data for certain specific patient groups remains limited or lacking.

Q: How is Felodipine eliminated from the body?

A: Felodipine is extensively metabolized (broken down) by the liver via the CYP3A4 enzyme system. The resulting inactive substances are primarily eliminated from the body via the urine, with a smaller amount also excreted in the feces.

Q: Why are people told to avoid excessive sun exposure when taking Felodipine?

A: Caution with sun exposure may be suggested, as photosensitivity reactions (increased sensitivity to sunlight) are listed in the official documentation as a very rare side effect. Protecting the skin from excessive sun exposure can help minimize this risk.

Q: How does the mechanism of action of Felodipine differ from ACE inhibitors?

A: Felodipine is a calcium channel blocker that relaxes arteries through the direct blockade of calcium entry into the vessel walls. This is distinct from ACE inhibitors, which work by blocking the body’s production of Angiotensin II, a chemical that narrows blood vessels. Both drug classes lower blood pressure but through different internal pathways.

Q: How common is the flushing or reddening of the face with Felodipine?

A: Flushing, which can appear as a reddening of the face or skin, is listed in the regulatory documentation as a common side effect, meaning it is experienced by 1% to 10% of patients. Like other common side effects, it is often transient, meaning it may lessen over time.

Q: What kinds of food should be avoided while taking Felodipine other than grapefruit?

A: Beyond avoiding grapefruit and grapefruit juice entirely due to known drug interactions, official instructions recommend caution with certain meal types. Specifically, the tablet should not be taken with a heavy meal or a meal rich in fat or carbohydrates, as this may interfere with how the extended-release tablet is absorbed.

Q: Can Felodipine cause vision changes?

A: Regulatory documents list vision-related changes as rare adverse events. These can include blurred vision and, very rarely, disturbed color perception. Any changes in vision after starting this medication should be reported to a healthcare provider.

Q: Can Felodipine cause a dry cough?

A: Reports of a cough are mentioned in the official safety information, based on post-marketing surveillance data. If a persistent dry cough develops after starting Felodipine, it should be discussed with a doctor, as cough is more frequently associated with other classes of blood pressure medication.

Q: Does Felodipine cause weight gain or loss?

A: Official adverse event lists include unusual weight gain or loss in the less common categories. While not a frequent side effect, any significant and unexplained change in body weight should be addressed with a healthcare provider.

Q: Can men with fertility concerns take Felodipine?

A: Based on non-clinical and post-marketing data reviews, official regulatory information indicates there is no evidence to suggest that taking Felodipine reduces fertility in men or women. However, men with existing fertility concerns should consult their healthcare provider.

Q: Is it safe to drive while taking Felodipine?

A: Official information indicates that Felodipine can have a minor or moderate influence on the ability to drive or operate machinery. Caution is advised, particularly when starting treatment, until an individual knows how the medicine affects them, especially concerning side effects like dizziness or fatigue.

Q: What is the target age group for Felodipine prescriptions?

A: Felodipine is officially indicated for the treatment of hypertension (high blood pressure) in adults. Its safety and efficacy profile has been primarily established for use in the adult population.

Q: Does Felodipine affect kidney function over time?

A: The pharmacological action of Felodipine is not typically associated with harming normal kidney function. Studies suggest it generally does not affect the Glomerular Filtration Rate (GFR) and may even help by increasing blood flow to the kidneys, which can be beneficial.

How should Felodipine be stored and disposed of?

Official Storage and Disposal Instructions

Felodipine extended-release tablets must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with regulatory permission for excursions up to 30 C (86 F). The product must be stored away from excess heat and moisture and should be protected from light.

Storage Requirement Condition
Temperature Restriction Do not freeze.
Container Condition Keep in the closed container and ensure it is tightly closed.
Child Safety Store out of the reach and sight of children.

All unused or expired medicine must be disposed of in accordance with local requirements for pharmaceutical waste. Do not keep outdated medicine; consult a healthcare professional regarding proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Felodipine found in:

A-Z Index: